Patents by Inventor Brian Nichelson

Brian Nichelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA
    Publication number: 20060287310
    Abstract: This invention relates to compounds of the formula 1 wherein G, D, A, Z, Q, X, Y, R1, and R4 through R7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
    Type: Application
    Filed: August 24, 2006
    Publication date: December 21, 2006
    Inventors: Jerry Clark, Jamie Davis, David Favor, Lorraine Fay, Lloyd Franklin, Kevin Henegar, Douglas Johnson, Brian Nichelson, Ligong Ou, Joseph Repine, Michael Walters, Andrew White, Zhijian Zhu
  • [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA
    Publication number: 20060287309
    Abstract: This invention relates to compounds of the formula 1 wherein G, D, A, Z, Q, X, Y, R1, and R4 through R7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
    Type: Application
    Filed: August 24, 2006
    Publication date: December 21, 2006
    Inventors: Jerry Clark, Jamie Davis, David Favor, Lorraine Fay, Lloyd Franklin, Kevin Henegar, Douglas Johnson, Brian Nichelson, Ligong Ou, Joseph Repine, Michael Walters, Andrew White, Zhijian Zhu
  • [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
    Publication number: 20050043309
    Abstract: This invention relates to compounds of the formula 1 wherein G, D, A, Z, Q, X, Y, R1, and R4 through R7 are defined as in the specification, processes for preparing the same and intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
    Type: Application
    Filed: July 28, 2004
    Publication date: February 24, 2005
    Inventors: Jerry Clark, Jamie Davis, David Favor, Lorraine Fay, Lloyd Franklin, Kevin Henegar, Douglas Johnson, Brian Nichelson, Ligong Ou, Joseph Repine, Michael Walters, Andrew White, Zhijian Zhu